Bank of New York Mellon Corp Buys 6,295 Shares of National Research Co. (NASDAQ:NRC)

Bank of New York Mellon Corp boosted its stake in National Research Co. (NASDAQ:NRC) by 5.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 123,255 shares of the company’s stock after acquiring an additional 6,295 shares during the quarter. Bank of New York Mellon Corp’s holdings in National Research were worth $2,829,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in National Research by 1.1% during the 1st quarter. Vanguard Group Inc. now owns 944,995 shares of the company’s stock worth $37,431,000 after buying an additional 10,351 shares in the last quarter. Conestoga Capital Advisors LLC lifted its position in National Research by 0.5% during the 1st quarter. Conestoga Capital Advisors LLC now owns 784,656 shares of the company’s stock worth $31,080,000 after buying an additional 3,850 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in National Research by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 636,402 shares of the company’s stock worth $25,176,000 after buying an additional 7,531 shares in the last quarter. PineStone Asset Management Inc. lifted its position in National Research by 128.9% during the 4th quarter. PineStone Asset Management Inc. now owns 153,100 shares of the company’s stock worth $6,057,000 after buying an additional 86,202 shares in the last quarter. Finally, Norden Group LLC bought a new stake in National Research during the 1st quarter worth about $5,170,000. 47.26% of the stock is owned by institutional investors.

National Research Trading Up 1.2 %

Shares of NASDAQ:NRC opened at $21.90 on Monday. The company’s 50-day moving average price is $22.67 and its two-hundred day moving average price is $29.05. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.37 and a quick ratio of 0.37. National Research Co. has a one year low of $20.41 and a one year high of $47.25. The stock has a market capitalization of $522.91 million, a PE ratio of 17.66 and a beta of 0.48.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.26 EPS for the quarter. The firm had revenue of $35.02 million for the quarter. National Research had a net margin of 20.01% and a return on equity of 63.64%.

National Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.19%. National Research’s dividend payout ratio is presently 38.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.